For: | Aljabban J, Rohr M, Syed S, Khorfan K, Borkowski V, Aljabban H, Segal M, Mukhtar M, Mohammed M, Panahiazar M, Hadley D, Spengler R, Spengler E. Transcriptome changes in stages of non-alcoholic fatty liver disease. World J Hepatol 2022; 14(7): 1382-1397 [PMID: 36158924 DOI: 10.4254/wjh.v14.i7.1382] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v14/i7/1382.htm |
Number | Citing Articles |
1 |
Elena Cristina Rusu, Helena Clavero-Mestres, Mario Sánchez-Álvarez, Marina Veciana-Molins, Laia Bertran, Pablo Monfort-Lanzas, Carmen Aguilar, Javier Camaron, Teresa Auguet. Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery. Computers in Biology and Medicine 2025; 191: 110170 doi: 10.1016/j.compbiomed.2025.110170
|
2 |
Mohammadreza Gholamrezapour, Raziyeh Taghizadeh Ghavamabadi, Mohammad Mohsen Taghavi, Samereh Dehghani Soltani, Ahmad Shabanizadeh, Reza Vazirinejad, Zahra Taghipour. Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells. Journal of Molecular Histology 2025; 56(1) doi: 10.1007/s10735-024-10313-2
|
3 |
Natacha Cerisier, Bryan Dafniet, Anne Badel, Olivier Taboureau. Linking chemicals, genes and morphological perturbations to diseases. Toxicology and Applied Pharmacology 2023; 461: 116407 doi: 10.1016/j.taap.2023.116407
|
4 |
Ruiyi Liu, Yan Sun, Dong Di, Xiyuan Zhang, Boran Zhu, Haoxin Wu.
PI3K/AKT/SERBP-1 pathway regulates
Alisma orientalis
beverage treatment of atherosclerosis in APOE
−/−
high-fat diet mice
. Pharmaceutical Biology 2023; 61(1): 473 doi: 10.1080/13880209.2023.2168020
|
5 |
Miguel D. Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda, Antoni Pons. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants 2023; 12(3): 711 doi: 10.3390/antiox12030711
|
6 |
Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy. Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease. International Journal of Biological Macromolecules 2024; 282: 137235 doi: 10.1016/j.ijbiomac.2024.137235
|
7 |
Aylin Acun, Letao Fan, Ruben Oganesyan, Korkut M. Uygun, Heidi Yeh, Martin L. Yarmush, Basak E. Uygun. Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to be used as a Platform for iPSC‐Hepatocyte Culture. Advanced Healthcare Materials 2024; 13(13) doi: 10.1002/adhm.202302943
|
8 |
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui. Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease. Livers 2023; 3(4): 687 doi: 10.3390/livers3040045
|